Fermium Research keeps DuPont de Nemours at Buy, lifts target to $160

what happened

Fermium Research kept its Buy rating on DuPont de Nemours and lifted its price target to $160 from $154, a 3.9% increase, according to TradingView. The new target implies 13.2% upside from the November 2 close of $141.30.

Across the five most recent analyst notes from the past 30 days, targets range from $145 to $172. RBC maintained Outperform at $160 on October 15, Barclays initiated coverage at Overweight with a $156 target on October 13, and JP Morgan downgraded the stock to Neutral with a $145 target on October 9. Citigroup kept Buy at $162 on October 7, and UBS maintained Buy at $172 on October 5.

why it matters

For investors, these updates show how large brokers view DuPont's outlook, though a single rating change does not alter the company's fundamentals. The wide spread between $145 and $172 signals differing views on the stock's earnings potential. This is a routine analyst action rather than a company announcement, and it is not a recommendation to buy or sell.

tags

instruments